A novel and generalizable organotypic slice platform to evaluate stem cell potential for targeting pediatric brain tumors

doi:10.1186/1475-2867-8-9

Cancer Cell International

Volume 8

Viewing options:

Abstract
Full text
PDF (980KB)
Additional files

Associated material:

Related literature:

Articles citing this article
on Google Scholar
on PubMed Central
Other articles by authors
on Google Scholar

Li SC
Loudon WG

on PubMed

Li SC
Loudon WG
Related articles/pages
on Google

on Google Scholar

on PubMed

Tools:

Post to:

Hypothesis

A novel and generalizable organotypic slice platform to evaluate stem cell potential for targeting pediatric brain tumors

Shengwen Calvin Li¹^,2^,4^,5 and William Gunter Loudon¹^,3

¹Center for Neuroscience and Stem Cell Research, Neuroscience Institute, Children's Hospital of Orange County Research Institute, 455 S. Main Street, Orange, CA 92868, USA

²Department of Neurology, University of California Irvine, Orange, CA 92862-4280, USA

³Department of Neurological Surgery, University of California Irvine, Orange, CA 92868-3298, USA

⁴Department of Cancer Biology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA

⁵Department of Biological Science, California State University, Fullerton, CA 92834, USA

author email corresponding author email

Cancer Cell International 2008, 8:9doi:10.1186/1475-2867-8-9


Published:	22 May 2008

Additional files

Additional file 1:

Table 2. Current Clinical trials Using Stem Cells for Treatment of Pediatric Brain Tumors.The data provided represent the current status of stem cell therapy of pediatric brain tumors worldwide (The data are from ClinicalTrials.gov, a registry of federally and privately supported clinical trials conducted in the United States and around the world. HSC: Hematopoietic Stem Cell; PBSC: peripheral blood stem cells)

Format: XLS Size: 22KB Download file

This file can be viewed with: Microsoft Excel Viewer